0001209191-24-001146.txt : 20240108
0001209191-24-001146.hdr.sgml : 20240108
20240108163904
ACCESSION NUMBER: 0001209191-24-001146
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240104
FILED AS OF DATE: 20240108
DATE AS OF CHANGE: 20240108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silberman David
CENTRAL INDEX KEY: 0001867998
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35813
FILM NUMBER: 24520688
MAIL ADDRESS:
STREET 1: 20 MAMILLA AVENUE
CITY: JERUSALEM
STATE: L3
ZIP: 9414904
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ORAMED PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001176309
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 980376008
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
BUSINESS PHONE: 646-844-1164
MAIL ADDRESS:
STREET 1: 1185 AVENUE OF THE AMERICAS, 3RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: Integrated Security Technologies, Inc.
DATE OF NAME CHANGE: 20040614
FORMER COMPANY:
FORMER CONFORMED NAME: IGUANA VENTURES LTD
DATE OF NAME CHANGE: 20020625
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-04
0
0001176309
ORAMED PHARMACEUTICALS INC.
ORMP
0001867998
Silberman David
20 MAMILLA AVENUE
JERUSALEM
L3
9414904
ISRAEL
0
1
0
0
Chief Financial Officer
0
Common Stock
2024-01-04
4
A
0
136500
A
366500
D
Represents Restricted Stock Units ("RSUs") that will vest in equal quarterly installments of 11,375 over a three year period starting January 8,
2024. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.
/s/ David Silberman
2024-01-08